Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients

NCT00512642 is registered in ClinicalTrials.gov with National Institute of Environmental Health Sciences (NIEHS) as lead sponsor.

NCT NCT00512642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00512642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients
Lead sponsor
National Institute of Environmental Health Sciences (NIEHS)
Phase
Observational
Overall status
Completed
Start date
July 29, 1999
Completion date
November 19, 2019
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer